Loading...
ArcticZymes Technologies Community
OB:AZT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
Community Investing Ideas
Precision Medicine Will Continue Advancing Through Biomanufacturing And Gene Therapies
Key Takeaways Strong biomanufacturing growth and broader revenue streams are fueled by robust product adoption and expansion into new advanced therapeutics markets. Enhanced commercial execution, geographic reach, and operational scalability position the company for stable, long-term, high-margin revenue growth.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
NOK 32
29.7% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
20.46% p.a.
Profit Margin
30.89%
Future PE
43.44x
Share price in 2028
NOK 37.69